UNC Health Joins Promising Multicenter Clinical Trial for Glioblastoma
UNC Health is now enrolling patients as part of a multicenter clinical trial for newly diagnosed glioblastoma (GBM) patients. The phase 2b clinical study administers a combination immunotherapy developed by biotech company, Imvax. UNC Health is one of multiple academic health care centers across the country participating in the randomized trial that aims to enroll … Read more